Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

NIH seeks licensees and/or CRADA partners for development of HCV vaccine

Feb. 9, 1999

Novartis describes new PNP inhibitor series in recent patent literature

Feb. 8, 1999

Novel ferrioxamine immunosuppressant discovered at Japanese research institutes

Feb. 5, 1999

Abgenix reports positive preliminary results from phase II trial of GVHD treatment

Feb. 5, 1999

EMEA marketing approval for Triacelluvax

Feb. 4, 1999

New immunomodulator LK-423 possesses unique pharmacological properties

Feb. 3, 1999

Clinical trials for Japanese immunosuppressant begin in Europe

Feb. 3, 1999

Priority review status assigned to Rapamune immunosuppressive therapy

Feb. 3, 1999

New herpes vaccine from Cel-Sci proves effective in protecting mice

Feb. 1, 1999

OraVax, Peptide Therapeutics and Pasteur Merieux Connaught announce agreements

Feb. 1, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...